Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections

NCT03445195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection
Acute Pyelonephritis

Interventions

DRUG: Sulbactam-ETX2514
DRUG: Placebo
DRUG: Imipenem-cilastatin

Sponsor

Entasis Therapeutics